From: Kawasaki disease associated with Mycoplasma pneumoniae
MP + KD+ Group | MP-KD+ Group | P value | |
---|---|---|---|
No. of patients (%) | 62 (13.7) | 388 (86.3) | - |
Median age (quartiles), m | 25 (17, 48) | 14.5 (8, 29) | <0.01* |
Male to female ratio | 1.82 | 1.91 | 0.62 |
Median fever duration before the diagnosis of KD (quartiles), days | 7 (5, 8) | 6 (5, 7) | 0.14* |
Rash, n (%) | 49 (79.0) | 294 (75.8) | 0.57 |
Conjunctival injection, n (%) | 50 (80.6) | 323 (83.2) | 0.61 |
Changes in extremities, n (%) | 51 (82.3) | 298 (76.8) | 0.34 |
Cervical lymphadenopathy, n (%) | 43 (69.4) | 233 (60.1) | 0.16 |
Mucosal changes, n (%) | 55 (88.7) | 340 (87.6) | 0.81 |
ESR, mm/h | 39.9 ± 25.4 | 35.4 ± 24.0 | 0.03* |
WBC, ×109/L | 14.6 ± 6.4 | 14.1 ± 5.0 | 0.45 |
PLT, ×109/L | 369.8 ± 130.1 | 381.5 ± 125.4 | 0.30 |
N% | 68.6 ± 13.8 | 64.0 ± 15.9 | <0.01* |
CRP, mg/L | 70.6 ± 15.6 | 64.7 ± 15.1 | <0.01* |